A randomized, open-label, comparative study for Edoxaban and

Recruiting

1 years - 99 years

All

Phase 3

1 Location

Brief description of study

The purpose of this study is to compare edoxaban with warfarin to see if it is safe and effective in preventing thromboembolism (formation of a clot [thrombus] in a blood vessel that breaks loose and is carried by the blood stream to block another vessel) and strokes which results when a brain blood vessel becomes blocked by a clot and in patients with AF who have undergone electrical cardioversion.

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Atrial Fibrillation,atrial fibrillation
Age: 1 years - 99 years
Gender: All

Updated on 19 Feb 2024. Study ID: 820126

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.

A randomized, open-label, comparative study for Edoxaban and Enoxaparin/Warfarin vs Warfarin alone in subjects with Atrial Fibrillation who have undergone Electrical Cardioversion

Brief description of study

Detailed description of study

Eligibility of study

Find a site